Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial. oleh Reece Holbrook, Lucas Higuera, Kael Wherry, Dave Phay, Yu-Cheng Hsieh, Kuo-Hung Lin, Yen-Bin Liu